- Danish stocks
- First North Copenhagen
- Bavarian Nordic
- Chr. Hansen
- DanDrit Biotech
- GN Store Nord
- Novo Nordisk
- Veloxis Pharmaceuticals
- William Demant
- Zealand Pharma
- Norwegian stocks
- Swedish stocks
- A1M Pharma
- Accelerator Nordic
- Clinical Laserthermia
- Eurocine Vaccines
- European Inst. of Science
- IDL Biotech
- Medfield Diagnostics
- Micropos Medical
- Rubicon Life Science
- SPAGO Imaging
- Vivoline Medical
- First North Stockholm
- OMX Stockholm A-F
- OMX Stockholm G-Z
- US stocks
- General discussion
- All posts
Apaziquone multiple installation fully enrolled
By Investor1989 On 15. September 2012 · Leave a Comment · In Spectrum
I have emailed Spectrum IR, but i never got any answers. But than i start emailing with David Nakasone from Allergans investor relations. He is a really good person, and he is very helpful with questions regarding Apaziquone. I asked david about why the status on the multiple installation study changed august 2 2012 to “active not recruiting”. he told me that it means that the study is ongoing and the recruitment IS COMPLETE. Now they are just analysing the data and waiting for all events to accour. They have fully enrolled this study in 10-11 months. The two single installation studies took 26 months to recruit.
but in the single installation study, the primary endpoint was reccurance rate after 24 months. It is not the endpoint in this multiple installation study. The endpoint is time to reccurance: “Time to recurrence (from randomization) for eligible patients with Low- intermediate risk NMIBC, who had undergone TURBT followed by, a single instillation of apaziquone immediately post TURBT and multiple instillations of apaziquone or placebo.”
That actually means that interim data from this study can come in the next 12 months and full data in 24 months well sooner than i ealier anticipated.
Also note that we do have some really positive phase II data in multiple installation..
Investor in stocks in about 5 years with some very good profits. Focusing on Biotech and Value stocks. Active investor...
- Spectrum a future Winner Being a Danish investor I first learned about Spectrum Pharmaceuticals...
- The Spectrum Pharmaceuticals “Bio CEO Conference”: Yesterday BIO CEO Conference from Spectrum Pharmaceuticals was as expected....
- Spectrum 10 års jubilæum Nu er der en masse snak omkring Spectrum aktien for...
- Spectrum as an Investment (and some thoughts on TopoTarget) This is a short (sort of ) article about Investment...
- Lesliejek on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Patrickciz on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Jameskipse on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Rickiehiela on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife